Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
Gut dysbiosis in Down syndrome: A potentially unexplored culprit for early Alzheimer's disease.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rosas Herminia Diana, Morgan Xochitl C, Tao Yiran, Lai Florence, Mercaldo Nathaniel D
Аннотация
INTRODUCTION: Gut dysbiosis has been found to play a role in sporadic Alzheimer's disease (AD) but has not been explored in Down syndrome (DS), despite the strong relationship between DS and early AD. Here, we compared the gut microbiomes of 20 adults with DS, either cognitively stable or with mild cognitive impairment.
METHODS: DNA from stool samples was profiled using 16S rRNA sequencing.
RESULTS: Cognitive status was associated with a significant difference in overall microbiome composition (p < 0.01) and with significant differences in the abundance of Bacteroidaceae, Enterobacteriaceae, and Christensenellaceae.
CONCLUSION: Just as in sporadic AD, AD in DS is associated with gut dysbiosis. Our work suggests that this is an important area for future investigation, one that may provide a novel and important target for therapeutic intervention.
HIGHLIGHTS: Alterations in the gut microbiome are present in adults with Down syndrome (DS) with mild cognitive impairment (MCI). Increased taxa in DS-MCI that contribute to inflammation and disrupt blood-brain barrier. Suggests a possible role of gut dysbiosis in Alzheimer's disease in adults with DS.
METHODS: DNA from stool samples was profiled using 16S rRNA sequencing.
RESULTS: Cognitive status was associated with a significant difference in overall microbiome composition (p < 0.01) and with significant differences in the abundance of Bacteroidaceae, Enterobacteriaceae, and Christensenellaceae.
CONCLUSION: Just as in sporadic AD, AD in DS is associated with gut dysbiosis. Our work suggests that this is an important area for future investigation, one that may provide a novel and important target for therapeutic intervention.
HIGHLIGHTS: Alterations in the gut microbiome are present in adults with Down syndrome (DS) with mild cognitive impairment (MCI). Increased taxa in DS-MCI that contribute to inflammation and disrupt blood-brain barrier. Suggests a possible role of gut dysbiosis in Alzheimer's disease in adults with DS.